Infectious Diseases Doctors’ Knowledge of Psychedelics
The interest of Gerontology professionals in exploring psychedelics stems from their potential in addressing mental health concerns prevalent in aging populations. Psychedelics like psilocybin and MDMA have shown promise in alleviating conditions like depression, anxiety, and end-of-life distress, common among older adults.
Exploration in gerontology involves understanding how psychedelics might positively impact the mental well-being and quality of life of older individuals. However, this interest requires careful consideration of safety, dosage, and potential interactions with existing medications.
The focus on mental health benefits, especially in addressing existential distress or anxiety related to aging or terminal illnesses, could offer new avenues for improving the overall well-being of older adults. Yet, due to limited research and potential risks, Gerontology professionals would approach this field cautiously. Rigorous studies, tailored for older populations, are necessary to understand the efficacy, safety, and ethical implications of using psychedelics as a therapeutic option in geriatric care before any practical applications.
Entheogen-assisted Healing
Taking entheogens can be like air travel: people do it all the time, it’s usually fine, but when it’s not fine, it’s sometimes very bad. We’ve been there. And that’s where an experienced GUIDE can make the difference in the outcome.
I’m available by phone if you or someone you know wants to ask questions of ANY nature. Use this link to schedule a call HERE.